/cloudfront-us-east-2.images.arcpublishing.com/reuters/QNLD5PNTZJLNHOKDCWUIG7Y2J4.jpg)
FILE PHOTO: The logo of Danish drugmaker Novo Nordisk, Copenhagen, Denmark, September 26, 2023. REUTERS/Tom Little/File Photo Acquire Licensing Rights LONDON, Nov 13 (Reuters) – Novo Nordisk (NOVOb.CO) shares rose 3% on Monday as the market reacted to data the drugmaker presented over the weekend showing that the heart protective benefits of its popular obesity … Read more
/cloudfront-us-east-2.images.arcpublishing.com/reuters/7XXQIDEIWRKN3NZA62CUCEHSMM.jpg)
A 0.25 mg injection pen of Novo Nordisk’s weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, September 1, 2023. REUTERS/Victoria Klesty/Illustration/File Photo Acquire Licensing Rights PHILADELPHIA, Nov 11 (Reuters) – Novo Nordisk (NOVOb.CO) on Saturday said the heart protective benefits of its wildly popular Wegovy obesity treatment are due to more … Read more
/cloudfront-us-east-2.images.arcpublishing.com/reuters/FAQTJ67KUNKL3H6NZ4DIJMOMOI.jpg)
The logo of Lilly is seen on a wall of the Lilly France company unit, part of the Eli Lilly and Co drugmaker group, in Fegersheim near Strasbourg, France, February 1, 2018. Picture taken February 1, 2018. REUTERS/Vincent Kessler/File Photo Acquire Licensing Rights Sept 8 (Reuters) – Eli Lilly’s (LLY.N) diabetes drug Mounjaro has gained … Read more